Skip to content

Modified Versus Conventional Serratus Anterior Plane Block

Ultrasound Guided Modified Versus Conventional Serratus Anterior Plane Block as a Preemptive Analgesia for Unilateral Video-Assisted Thoracoscopic Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05661253
Enrollment
99
Registered
2022-12-22
Start date
2022-12-02
Completion date
2023-10-30
Last updated
2023-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Acute

Brief summary

comparing preemptive analgesia with ultrasound guided modified serratus anterior plane block versus ultrasound guided serratus anterior plane block

Detailed description

comparing the quality of postoperative analgesia and opioid consumption in patients undergoing Video-Assisted Thoracoscopic Surgery when using preemptive analgesia with ultrasound guided modified serratus anterior plane block versus ultrasound guided serratus anterior plane block

Interventions

DRUG25 ml of bupivacaine 0.25% via serratus anterior block

patients will receive conventional serratus anterior plane block with a volume of 25 ml of bupivacaine 0.25% followed by induction of general anesthesia,

DRUG25 ml of bupivacaine 0.25% via modified serratus anterior palne block

patients will receive modified serratus anterior plane block with a volume of 25 ml of bupivacaine 0.25% followed by induction of general anesthesia.

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient consent. * both sex. * Age: 21-70 years old. * BMI: 18- 30 kg/m2 * ASA: I and II. * Scheduled for elective unilateral Video-Assisted thoracoscopy under general anesthesia.

Exclusion criteria

* History of allergy to the local anesthesia agents used in this study, * Skin lesion at needle insertion site, * Those receiving anticoagulant therapy or having bleeding disorders * Patients with history of chronic pain and taking analgesics, * Patients with sepsis and Significant cardiac, liver or renal diseases * Uncooperative patients or with psychiatric disorders.

Design outcomes

Primary

MeasureTime frameDescription
tramadol consumptionat 24 hours postoperativeThe amount of tramadol consumption at 24

Secondary

MeasureTime frameDescription
Time of performancefrom ultrasound probe positioning till the end of the block procedureTime of performance of block defined as time from ultrasound probe positioning till the end of the block procedure
Time to first dose of rescue analgesiaduring the first postoperative 24 hoursTime to first dose of rescue analgesia (VAS \> 3) after surgery
Patient satisfactionat 24 hous post operativePatient satisfaction with analgesia in the first 24hours postoperative hours will be Likert scale where 5 is very satisfied and 0 is very dissatisfied.

Countries

Egypt

Contacts

Primary ContactHeba M Fathi
heba_elgendi@yahoo.com002-01000143938

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026